Luciane Pons DiLeone

A Phase I Trial of Cisplatin Plus Decitabine, a New DNA-Hypomethylating Agent, in Patients with Advanced Solid Tumors and a Follow-Up Early Phase II Evaluation in Patients with Inoperable Non-Small Cell Lung Cancer

Gilberto Schwartsmann, Holger J. Schünemann, Chistopher Gorini et al. · Investigational New Drugs · 2000 · 111 citations

Medicine, Cisplatin Plus Decitabine, New Dna-hypomethylating Agent +9

Phase II Trial of Cisplatin Plus Decitabine, a New DNA Hypomethylating Agent, in Patients With Advanced Squamous Cell Carcinoma of the Cervix

Paula R. Pohlmann, Luciane Pons DiLeone, Anna Cancella et al. · American Journal of Clinical Oncology · 2002 · 86 citations

A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies

Gilberto Schwartsmann, Luciane Pons DiLeone, Marc E. Horowitz et al. · Investigational New Drugs · 2006 · 76 citations

Oncology, Bombesin/gastrin-releasing Peptide, Medicine +7

Fractionated Doses of Oral Etoposide in the Treatment of Patients With AIDS-Related Kaposi Sarcoma

Eduardo Sprinz, Ana Paula Ferrary Caldas, D.R.A. Mans et al. · American Journal of Clinical Oncology · 2001 · 20 citations

Quantification of the bombesin/gastrin releasing peptide antagonist RC-3095 by liquid chromatography–tandem mass spectrometry

Alberto dos Santos Pereira, Luciane Pons DiLeone, Fabiano H. Souza et al. · Journal of Chromatography B · 2004 · 13 citations

Biochemistry, Medicine, Mass Spectrometry +8